82铷PET心肌血流储备对心脏移植长期随访的预后价值
单中心回顾性研究评估心脏移植后长期随访中82铷PET获得的心肌血流储备(MFR)的预后价值。50例受者按MFR≤2.0 vs >2.0分组,中位随访3.6年,高MFR组生存概率显著更高(log-rank P=.02),低MFR组血运重建、新发CAV和移植物衰竭更常见。
要点
- 心脏移植后长期随访中,82铷PET测得的MFR可能具有预后价值。
- 高MFR组(>2.0)生存概率显著高于低MFR组(≤2.0)(log-rank P=.02)。
- 低MFR组血运重建、新发CAV诊断和移植物衰竭更频繁。
核心结论
- 心肌血流储备在部分长期心脏移植受者中似乎具有预后价值,有望作为CAV监测的非侵入性方法并可能指导管理策略。
研究设计与样本
- 单中心回顾性研究,纳入2013年4月至2017年6月期间接受动态静息-负荷82铷PET的50例心脏移植受者(68%男性,中位年龄57岁[IQR: 43至68])。
主要发现
- 从心脏移植到PET的中位时间为10.0年(IQR: 6.7至16.0),58%的患者在PET前已记录CAV。
- 中位随访3.6年(IQR: 2.3至4.3)期间发生12例事件,Kaplan-Meier生存概率在高MFR组显著更高(log-rank P=.02)。
- 低MFR患者中血运重建(n=1)、新发CAV诊断(n=1)和移植物衰竭(n=4)更常见,无再次移植发生。
关键数值与推荐
- 患者按MFR≤2.0 vs MFR>2.0分组,主要结局为全因死亡率。
临床怎么用
- 在长期心脏移植受者中,可考虑采用82铷PET测量的MFR辅助CAV监测和预后评估。
局限性
- 单中心回顾性研究,样本量50例,事件数12例,结论需更大样本验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cardiac allograft vasculopathy (CAV) is a leading cause of death following heart transplantation (HTx) and non-invasive prognostic methods in long-term CAV surveillance are needed. We evaluated the prognostic value of myocardial flow reserve (MFR) obtained by 82-rubidium (82Rb) positron emission tomography (PET). METHODS: Recipients undergoing dynamic rest-stress 82Rb PET between April 2013 and June 2017 were retrospectively evaluated in a single-center study. Evaluation by PET included quantitative myocardial blood flow and semiquantitative myocardial perfusion imaging. Patients were grouped by MFR (MFR ≤ 2.0 vs MFR > 2.0) and the primary outcome was all-cause mortality. RESULTS: A total of 50 patients (68% men, median age 57 [IQR: 43 to 68]) were included. Median time from HTx to PET was 10.0 (6.7 to 16.0) years. In 58% of patients CAV was documented prior to PET. During a median follow-up of 3.6 (2.3 to 4.3) years 12 events occurred. Survival probability by Kaplan-Meier method was significantly higher in the high-MFR group (log-rank P = .02). Revascularization (n = 1), new CAV diagnosis (n = 1), and graft failure (n = 4) were more frequent in low-MFR patients. No retransplantation occurred. CONCLUSIONS: Myocardial flow reserve appears to offer prognostic value in selected long-term HTx recipients and holds promise as a non-invasive method for CAV surveillance possibly guiding management strategy.
引用
- Nelson LM, Christensen TE, Rossing K, et al. Prognostic value of myocardial flow reserve obtained by 82-rubidium positron emission tomography in long-term follow-up after heart transplantation. J Nucl Cardiol. 2021. PMID: 34414554. doi:10.1007/s12350-021-02742-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。